医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Maternal inflammation during the second trimester of pregnancy with adverse birth outcomes:a prospective cohort study

摘要Background Distinct characteristics of maternal inflammation at midgestation related to fetal and neonatal health are not clear.This study aims to explore the associations between the maternal circulating inflammatory profile during the second trimester of pregnancy and a series of adverse birth outcomes.Methods The present study was a prospective cohort study based on the Born in Guangzhou Cohort Study conducted in Guangzhou,China.Peripheral blood samples from women were obtained during the second trimester.Adverse newborn outcomes were collected through electronic medical records at birth and within the first week after birth.We used logistic,Poisson and generalized linear regressions to assess the impact of inflammatory indicators during pregnancy on different outcomes.Results A total of 1567 singleton pregnant women were included.The proportions of preterm birth,small for gestational age(SGA),low birth weight(LBW),neonatal asphyxia and hyperbilirubinemia cases were 4.3%,6.6%,3.9%,1.1%and 12.6%,respectively.The maternal circulating level of log2-transformed interleukin(IL)-7 was positively associated with preterm birth[adjusted odds ratio(OR)=1.58,95%confidence interval(CI)=1.03-2.41].A higher level of log2-transformed IL-2 was correlated with increased LBW risk(adjusted OR=1.48,95%CI=1.09-2.02)and a decreased birth weight Z-score(adjusted β=-0.06,95%CI=-0.11,-0.01).IL-7 was associated with an increased risk of LBW(adjusted OR=1.80,95%CI=1.14-2.86),whereas log2-transformed IL-15 was positively related to SGA(adjusted OR=1.39,95%CI=1.02-1.91).There were no significant associations of maternal inflammatory indicators with neonatal asphyxia or hyperbilirubinemia.Conclusion Maternal circulating IL-2,IL-7 and IL-15 levels during the second trimester of pregnancy were associated with preterm birth or birth weight.

更多
广告
作者 Wan-Qing Xiao [1] Si-Chi Zhu [2] Zhu-Gu Huang [2] Qi-Wen He [3] Zi-Yin Lyu [4] Xu-Tao Li [2] Qing-Qun Lyu [2] Ya-Shu Kuang [3] Xue-Ling Wei [1] Dong-Mei Wei [1] Jin-Hua Lu [3] Jian-Rong He [1] Xiu Qiu [5] 学术成果认领
作者单位 The Born in Guangzhou Cohort Study Group,Department of Pediatrics,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Women's Health,Guangdong Provincial Key Clinical Specialty of Woman and Child Health,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China [1] School of Pediatrics,Guangzhou Medical University,Guangzhou 511436,China [2] The Born in Guangzhou Cohort Study Group,Department of Pediatrics,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China [3] The First School of Clinical Medicine,Guangzhou Medical University,Guangzhou 511436,China [4] The Born in Guangzhou Cohort Study Group,Department of Pediatrics,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Women's Health,Guangdong Provincial Key Clinical Specialty of Woman and Child Health,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Obstetrics and Gynecology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Guangdong Provincial Clinical Research Center for Child Health,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Provincial Key Laboratory of Research in Structure Birth Defect Disease,Department of Pediatric Surgery,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China [5]
栏目名称
DOI 10.1007/s12519-025-00909-3
发布时间 2025-07-23(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
世界儿科杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷